Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New York Daily Ledger.
Press releases published on September 3, 2025

RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

Shareholders who lost money in shares of LifeMD, Inc. (NASDAQ: LFMD) Should Contact Wolf Haldenstein Immediately
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman …

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTBD, WOW, SHCO, WKHS on Behalf of Shareholders
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: BT …

VAST Data Climbs the 2025 Forbes Cloud 100
Remote-First-Company | NEW YORK CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- VAST Data, the AI Operating System company, has been named to the prestigious 2025 Forbes Cloud 100 – the definitive ranking of the top 100 private cloud companies in the world, …

BlockitGroup Introduces Secret World, a Patented App Bringing New Jobs to 175+ Countries
BlockItGroup launches Secret World, the patented platform empowering independents through tasks, pop-ups, hiring, and deals — now live globally. NEW YORK CITY, NY, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- New York, NY – [2025/09/01] – …

Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
First-ever potentially disease-modifying therapy for uncontrolled Graves’ disease patients Of 21 patients who entered the six-month off-treatment follow-up period, ~80% (17/21) demonstrated response, resulting in normal thyroid function (T3 and T4 less …

Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
First-ever potentially disease-modifying therapy for uncontrolled Graves’ disease patients Of 21 patients who entered the six-month off-treatment follow-up period, ~80% (17/21) demonstrated response, resulting in normal thyroid function (T3 and T4 less …

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
Faruqi …

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics
Faruqi …

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience
Faruqi …

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
Faruqi …

Newsweek and Statista Reveal the World’s Most Trustworthy Companies 2025
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Newsweek and Statista today announced the World’s Most Trustworthy Companies 2025, recognizing 1,000 companies across 20 countries that have earned exceptional confidence from customers, employees, and investors …

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sable Offshore
Faruqi …

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PubMatic
Faruqi …

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages PubMatic, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PUBM
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PubMatic, Inc. (NASDAQ: PUBM) between February 27, 2025 and August 11, 2025, both dates inclusive (the “Class Period”), …

ROSEN, THE FIRST FILING FIRM, Encourages LifeMD, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – LFMD
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), of the …

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
Faruqi …

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
Faruqi …

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
Faruqi …

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SelectQuote
Faruqi …